Mogy Joel R Investment Counsel Inc Lowers stake in Henry Schein (HSIC)

Henry Schein (HSIC) : Mogy Joel R Investment Counsel Inc reduced its stake in Henry Schein by 0.12% during the most recent quarter end. The investment management company now holds a total of 38,625 shares of Henry Schein which is valued at $6,940,140 after selling 45 shares in Henry Schein , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.Henry Schein makes up approximately 1.25% of Mogy Joel R Investment Counsel Inc’s portfolio.

Other Hedge Funds, Including , Harel Insurance Investments Financial Services Ltd. added HSIC to its portfolio by purchasing 125 company shares during the most recent quarter which is valued at $22,460. Wagner Bowman Management Corp added HSIC to its portfolio by purchasing 1,310 company shares during the most recent quarter which is valued at $234,503. Henry Schein makes up approx 0.09% of Wagner Bowman Management Corp’s portfolio.Swedbank reduced its stake in HSIC by selling 77,130 shares or 3.93% in the most recent quarter. The Hedge Fund company now holds 1,885,554 shares of HSIC which is valued at $340,644,186. Henry Schein makes up approx 2.75% of Swedbank’s portfolio.Checchi Capital Advisers reduced its stake in HSIC by selling 43 shares or 5.42% in the most recent quarter. The Hedge Fund company now holds 750 shares of HSIC which is valued at $135,495. Henry Schein makes up approx 0.03% of Checchi Capital Advisers’s portfolio.

Henry Schein closed down -0.94 points or -0.56% at $166.02 with 9,33,975 shares getting traded on Monday. Post opening the session at $166.94, the shares hit an intraday low of $165.1 and an intraday high of $167.53 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Henry Schein reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $1.63. The company had revenue of $2872.60 million for the quarter, compared to analysts expectations of $2845.09 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Henry Schein - Is it time to Sell?

Top Brokerage Firms are advising their investors on Henry Schein. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.